申请人:Centre Europeen de Recherches Mauvernay
公开号:US04430332A1
公开(公告)日:1984-02-07
The invention is dealing with compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, in which R.sub.1 and R.sub.2 each represent a lower alkyl radical or a phenyl radical, or, together with the carbon atom to which they are bound, a cycloalkyl radical having at the most 7 carbon atoms; R.sub.3 represents hydrogen, a lower alkyl radical, or the phenyl radical; R.sub.4 and R.sub.5 each represent a lower alkyl radical, or, together with the nitrogen atom to which they are bound, a heterocyclic amino radical such as the pyrrolidinyl or morpholino radicals; and R.sub.6 represents a lower alkyl radical, a phenyl radical, a benzyl radical, or the 1-ethynyl-cyclohexyl radical, which compounds can be used in the treatment of angina pectoris.
该发明涉及以下式的化合物:##STR1##和其药学上可接受的盐,其中R.sub.1和R.sub.2分别表示较低的烷基基团或苯基,或与它们结合的碳原子一起,最多具有7个碳原子的环烷基基团; R.sub.3表示氢、较低的烷基基团或苯基; R.sub.4和R.sub.5分别表示较低的烷基基团,或与它们结合的氮原子一起,如吡咯啉基或吗啉基等杂环氨基基团; 而R.sub.6表示较低的烷基基团、苯基、苄基或1-乙炔基-环己基基团,这些化合物可用于治疗心绞痛。